Suppression of complement activation by recombinant Crry inhibits experimental autoimmune anterior uveitis (EAAU)

Molecular Immunology

Volumn 48, Issue 1-3, 2010, Pages 231-239

  Manickam, Balasubramanian ^a   Jha, Purushottam ^a   Hepburn, Natalie J ^b   Morgan, B Paul ^b   Harris, Claire L ^b   Bora, Puran S ^a   Bora, Nalini S ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

C3; Complement system; Crry (complement related gene protein y, 512 antigen); Membrane attack complex (MAC); Ocular autoimmunity; Uveitis

Indexed keywords

COMPLEMENT; COMPLEMENT RELATED PROTEIN Y IMMUNOGLOBULIN G; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN G2A; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; COMPLEMENT ACTIVATION; COMPLEMENT FACTOR; CONTROLLED STUDY; DISEASE COURSE; IMMUNIZATION; IRIDOCYCLITIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGENS, SURFACE; AUTOIMMUNE DISEASES; BLOTTING, WESTERN; COMPLEMENT ACTIVATION; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, INBRED LEW; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UVEITIS, ANTERIOR;

ANIMALIA; BOVINAE; RATTUS;

EID: 78649508975     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.08.006     Document Type: Article

References (54)

1. Bloch-Michel E., Nussenblatt R.B. International uveitis study group recommendations for the evaluation of intraocular inflammatory disease. Am. J. Ophthalmol. 1987, 103(2):234-235.
2. Bora N.S., Kim M.C., Kabeer N.H., Simpson S.C., Tandhasetti M.T., Cirrito T.P., Kaplan A.D., Kaplan H.J. Experimental autoimmune anterior uveitis. Induction with melanin-associated antigen from the iris and ciliary body. Invest. Ophthalmol. Vis. Sci. 1995, 36(6):1056-1066.
3. Bora N.S., Woon M.D., Tandhasetti M.T., Cirrito T.P., Kaplan H.J. Induction of experimental autoimmune anterior uveitis by a self-antigen: melanin complex without adjuvant. Invest. Ophthalmol. Vis. Sci. 1997, 38(10):2171-2175.
4. Bora N.S., Sohn J.H., Kang S.G., Cruz J.M., Nishihori H., Suk H.J., Wang Y., Kaplan H.J., Bora P.S. Type I collagen is the autoantigen in experimental autoimmune anterior uveitis. J. Immunol. 2004, 172(11):7086-7094.
5. Bora P.S., Sohn J.H., Cruz J.M., Jha P., Nishihori H., Wang Y., Kaliappan S., Kaplan H.J., Bora N.S. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J. Immunol. 2005, 174:491-497.
6. Bora N.S., Kaliappan S., Jha P., Xu Q., Sohn J.H., Dhaulakhandi D.B., Kaplan H.J., Bora P.S. Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H. J. Immunol. 2006, 177(3):1872-1878.
7. Bora N.S., Kaliappan S., Jha P., Xu Q., Sivasankar B., Harris C.L., Morgan B.P., Bora P.S. CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration. J. Immunol. 2007, 178(3):1783-1790.
8. Bora N.S., Kaplan H.J. Intraocular diseases-anterior uveitis. Chem. Immunol. Allergy 2007, 92:213-220.
9. Bora N.S., Jha P., Bora P.S. The role of complement in ocular pathology. Semin. Immunopathol. 2008, 30(2):85-95.
10. Broekhuyse R.M., Kuhlmann E.D., Winkens H.J., Van Vugt A.H. Experimental autoimmune anterior uveitis (EAAU), a new form of experimental uveitis. I. Induction by a detergent-insoluble, intrinsic protein fraction of the retinal pigment epithelium. Exp. Eye Res. 1991, 52(4):465-474.
11. Carroll M.C. The complement system in regulation of adaptive immunity. Nat. Immunol. 2004, 5(10):981-986.
12. Copland D.A., Hussain K., Baalasubramanian S., Hughes T.R., Morgan B.P., Xu H., Dick A.D., Nicholson L.B. Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. Clin. Exp. Immunol. 2010, 159(3):303-314.
13. Fava R.A., Gates C., Townes A.S. Critical role of peripheral blood phagocytes and the involvement of complement in tumour necrosis factor enhancement of passive collagen-arthritis. Clin. Exp. Immunol. 1993, 94(2):261-266.
14. Funabashi K., Okada N., Matsuo S., Yamamoto T., Morgan B.P., Okada H. Tissue distribution of complement regulatory membrane proteins in rats. Immunology 1994, 81:444-451.
15. Gaede K.I., Baumeister E., Heesemann J. Decomplementation by cobra venom factor suppresses Yersinia-induced arthritis in rats. Infect. Immun. 1995, 63:3697-3701.
16. Goodfellow R.M., Williams A.S., Levin J.L., Williams B.D., Morgan B.P. Soluble complement receptor one (sCR1) inhibits the development and progression of rat collagen-induced arthritis. Clin. Exp. Immunol. 2000, 119:210-216.
17. Gritz D.C., Wong I.G. Incidence and prevalence of uveitis in Northern California: the Northern California epidemiology of uveitis study. Ophthalmology 2004, 111(3):491-500.
18. Hartwig W., Jimenez R.E., Fernandez-del Castillo C., Kelliher A., Jones R., Warshaw A.L. Expression of the adhesion molecules Mac-1 and l-selectin on neutrophils in acute pancreatitis is protease- and complement-dependent. Ann. Surg. 2001, 233(3):371-378.
19. Hepburn N.J., Chamberlain-Banoub J.L., Williams A.S., Morgan B.P., Harris C.L. Prevention of experimental autoimmune myasthenia gravis by rat Crry-Ig: a model agent for long-term complement inhibition in vivo. Mol. Immunol. 2008, 45(2):395-405.
20. Hietala M.A., Jonsson I.M., Tarkowski A., Kleinau S., Pekna M. Complement deficiency ameliorates collagen-induced arthritis in mice. J. Immunol. 2002, 169:454-459.
21. Jha P., Sohn J.H., Xu Q., Nishihori H., Wang Y., Nishihori S., Manickam B., Kaplan H.J., Bora P.S., Bora N.S. The complement system plays a critical role in the development of experimental autoimmune anterior uveitis. Invest. Ophthalmol. Vis. Sci. 2006, 47(3):1030-1038.
22. Jha P., Sohn J.H., Xu Q., Wang Y., Kaplan H.J., Bora P.S., Bora N.S. Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU). J. Immunol. 2006, 176(12):7221-7231.
23. Jha P., Bora P.S., Bora N.S. The role of complement system in ocular diseases including uveitis and macular degeneration. Mol. Immunol. 2007, 44:3901-3908.
24. Jha P., Matta B., Lyzogubov V., Tytarenko R., Bora P.S., Bora N.S. Crucial role of apoptosis in the resolution of experimental autoimmune anterior uveitis. Invest. Ophthalmol. Vis. Sci. 2007, 48(11):5091-5100.
25. Jha P., Manickam B., Matta B., Bora P.S., Bora N.S. Proteolytic cleavage of type I collagen generates an autoantigen in autoimmune uveitis. J. Biol. Chem. 2009, 284(45):31401-31411.
26. Kaya Z., Afanasyeva M., Wang Y., Dohmen K.M., Schlichting J., Tretter T., Fairweather D., Holers V.M., Rose N.R. Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat. Immunol. 2001, 2:739-745.
27. Kilgore K.S., Shen J.P., Miller B.F., Ward P.A., Warren J.S. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J. Immunol. 1995, 155(3):1434-1441.
28. Kim M.C., Kabeer N.H., Tandhasetti M.T., Kaplan H.J., Bora N.S. Immunohistochemical studies on melanin associated antigen (MAA) induced experimental autoimmune anterior uveitis (EAAU). Curr. Eye Res. 1995, 14(8):703-710.
29. Kim Y.U., Kinoshita T., Molina H., Hourcade D., Seya T., Wagner L.M., Holers V.M. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J. Exp. Med. 1995, 181:151-159.
30. Linton S.M., Williams A.S., Dodd I., Smith R., Williams B.D., Morgan B.P. Therapeutic efficacy of a novel membrane-targeted complement regulator in antigen-induced arthritis in the rat. Arthritis Rheum. 2000, 43(11):2590-2597.
31. Marak G.E., Wacker W.B., Rao N.A., Jack R., Ward P.A. Effects of complement depletion on experimental allergic uveitis. Ophthalmic Res. 1979, 11:97-107.
32. + T-regulatory cells. Am. J. Pathol. 2008, 173(5):1440-1454.
33. + T-regulatory cells. Immunol. Cell Biol. 2010, 88(2):187-196.
34. McGrath Y., Wilkinson G.W., Spiller O.B., Morgan B.P. Development of adenovirus vectors encoding rat complement regulators for use in therapy in rodent models of inflammatory diseases. J. Immunol. 1999, 163(12):6834-6840.
35. Mizuno M., Nishikawa K., Morgan B.P., Matsuo S. Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59. Clin. Exp. Immunol. 2000, 119(2):368-375.
36. Mizuno M., Nishikawa K., Okada N., Matsuo S., Okada H. Soluble complement receptor type 1 protects rats from lethal shock induced by anti-Crry antibody following lipopolysaccharide priming. Int. Arch. Allergy Immunol. 2002, 127(1):55-62.
37. Mizuno M., Ito Y., Hepburn N., Mizuno T., Noda Y., Yuzawa Y., Harris C.L., Morgan B.P., Matsuo S. Zymosan, but not lipopolysaccharide, triggers severe and progressive peritoneal injury accompanied by complement activation in a rat peritonitis model. J. Immunol. 2009, 183(2):1403-1412.
38. Morgan B.P. Physiology and pathophysiology of complement: progress and trends. Crit. Rev. Clin. Lab. Sci. 1995, 32(3):265-298.
39. Morgan B.P., Harris C.L. Complement Regulatory Proteins 1999, Academic Press, San Diego.
40. Pasinetti G.M. Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system. Neurobiol. Aging 1996, 17(5):707-716.
41. Piddlesden S.J., Storch M.K., Hibbs M., Freeman A.M., Lassmann H., Morgan B.P. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J. Immunol. 1994, 152(11):5477-5484.
42. Quigg R.J., Lo C.F., Alexander J.J., Sneed A.E., Moxley G. Molecular characterization of rat Crry: widespread distribution of two alternative forms of Crry mRNA. Immunogenetics 1995, 42:362-367.
43. Quigg R.J., Kozono Y., Berthiaume D., Lim A., Salant D.J., Weinfeld A., Griffin P., Kremmer E., Holers V.M. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J. Immunol. 1998, 160(9):4553-4560.
44. Rehrig S., Fleming S.D., Anderson J., Guthridge J.M., Rakstang J., McQueen C.E., Holers V.M., Tsokos Shea-Donohue T. Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice. J. Immunol. 2001, 167(10):5921-5927.
45. Singhrao S.K., Neal J.W., Morgan B.P., Gasque P. Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease. Exp. Neurol. 1999, 159(2):362-376.
46. Sohn J.H., Kaplan H.J., Suk H.J., Bora P.S., Bora N.S. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Invest. Ophthalmol. Vis. Sci. 2000, 41:3492-3502.
47. Sohn J.H., Bora P.S., Suk H.J., Molina H., Kaplan H.J., Bora N.S. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat. Med. 2003, 9(2):206-212.
48. Tedesco F., Pausa M., Nardon E., Introna M., Mantovani A., Dobrina A. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J. Exp. Med. 1997, 185(9):1619-1627.
49. Tramontini N.L., Kuipers P.J., Huber C.M., Murphy K., Naylor K.B., Broady A.J., Kilgore K.S. Modulation of leukocyte recruitment and IL-8 expression by the membrane attack complex of complement (C5b-9) in a rabbit model of antigen-induced arthritis. Inflammation 2002, 26:311-319.
50. Tran G.T., Hodgkinson S.J., Carter N., Killingsworth M., Spicer S.T., Hall B.M. Attenuation of experimental allergic encephalomyelitis in complement component 6-deficient rats is associated with reduced complement C9 deposition, P-selectin expression, and cellular infiltrate in spinal cords. J. Immunol. 2002, 168:4293-4300.
51. Tsokos G.C. Complement in Autoimmunity 2004, Karger, Basel. G.C. Tsokos (Ed.).
52. Vaporciyan A.A., Mulligan M.S., Warren J.S., Barton P.A., Miyasaka M., Ward P.A. Up-regulation of lung vascular ICAM-1 in rats is complement dependent. J. Immunol. 1995, 155:1442-1449.
53. Vriesendorp F.J., Flynn R.E., Malone M.R., Pappolla M.A. Systemic complement depletion reduces inflammation and demyelination in adoptive transfer experimental allergic neuritis. Acta Neuropathol. (Berl.) 1998, 95:297-301.
54. Williams A.S., Mizuno M., Richards P.J., Holt D.S., Morgan B.P. Deletion of the gene encoding CD59a in mice increases disease severity in a murine model of rheumatoid arthritis. Arthritis Rheum. 2004, 50(9):3035-3044.